Surgical Management of Secondary and Tertiary Hyperparathyroidism.

Autor:	Bartz-Kurycki M; Surgical Services, James A. Haley Veterans Hospital, 13000 Bruce B. Downs Boulevard, Tampa, FL 33612, USA; Department of Surgery, University of South Florida, Tampa, FL, USA. Electronic address: https://twitter.com/MarisaBK6., Dream S; Division of Surgical Oncology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA. Electronic address: sdream@mcw.edu.
Jazyk:	angličtina
Zdroj:	The Surgical clinics of North America [Surg Clin North Am] 2024 Aug; Vol. 104 (4), pp. 825-835. Date of Electronic Publication: 2024 Mar 21.
DOI:	10.1016/j.suc.2024.02.011
Abstrakt:	Secondary hyperparathyroidism (SHPT) often arises from kidney disease and is characterized by elevated parathyroid hormone (PTH) levels. The reported optimal PTH level to balance the compensatory physiologic response in SHPT with the pathologic morbidity and mortality has changed over time with our evolving understanding. Parathyroidectomy for kidney-related hyperparathyroidism requires consideration of the patient's dialysis status, potential for kidney transplantation, and medical history. Extent of parathyroidectomy and intraoperative decision-making requires consideration to maximize cure with the risk of permanent hypoparathyroidism. Parathyroidectomy for kidney-related hyperparathyroidism can provide a reduction in morbidity, mortality, and improved kidney allograft function and survival. Competing Interests: Disclosure The authors have nothing to disclose. (Published by Elsevier Inc.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu